334 related articles for article (PubMed ID: 24291259)
1. Therapeutic antibody engineering by high efficiency cell screening.
Doerner A; Rhiel L; Zielonka S; Kolmar H
FEBS Lett; 2014 Jan; 588(2):278-87. PubMed ID: 24291259
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
3. Retrocyte Display® technology: generation and screening of a high diversity cellular antibody library.
Breous-Nystrom E; Schultze K; Meier M; Flueck L; Holzer C; Boll M; Seibert V; Schuster A; Blanusa M; Schaefer V; Grawunder U; Martin-Parras L; van Dijk MA
Methods; 2014 Jan; 65(1):57-67. PubMed ID: 24036249
[TBL] [Abstract][Full Text] [Related]
4. Isolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastoris.
Ryckaert S; Pardon E; Steyaert J; Callewaert N
J Biotechnol; 2010 Jan; 145(2):93-8. PubMed ID: 19861136
[TBL] [Abstract][Full Text] [Related]
5. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
7. Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.
Okamoto T; Mukai Y; Yoshioka Y; Shibata H; Kawamura M; Yamamoto Y; Nakagawa S; Kamada H; Hayakawa T; Mayumi T; Tsutsumi Y
Biochem Biophys Res Commun; 2004 Oct; 323(2):583-91. PubMed ID: 15369791
[TBL] [Abstract][Full Text] [Related]
8. Generation of Recombinant Monoclonal Antibodies from Immunised Mice and Rabbits via Flow Cytometry and Sorting of Antigen-Specific IgG+ Memory B Cells.
Starkie DO; Compson JE; Rapecki S; Lightwood DJ
PLoS One; 2016; 11(3):e0152282. PubMed ID: 27022949
[TBL] [Abstract][Full Text] [Related]
9. A novel strategy for generation of monoclonal antibodies from single B cells using rt-PCR technique and in vitro expression.
Jiang X; Suzuki H; Hanai Y; Wada F; Hitomi K; Yamane T; Nakano H
Biotechnol Prog; 2006; 22(4):979-88. PubMed ID: 16889373
[TBL] [Abstract][Full Text] [Related]
10. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
11. Engineering antibodies by yeast display.
Boder ET; Raeeszadeh-Sarmazdeh M; Price JV
Arch Biochem Biophys; 2012 Oct; 526(2):99-106. PubMed ID: 22450168
[TBL] [Abstract][Full Text] [Related]
12. [Construction and expression of single-chain Fv antibody against human VEGF].
Wang D; Yang X; Yuan Q
Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):526-9. PubMed ID: 11798812
[TBL] [Abstract][Full Text] [Related]
13. Single chain Fab (scFab) fragment.
Hust M; Jostock T; Menzel C; Voedisch B; Mohr A; Brenneis M; Kirsch MI; Meier D; Dübel S
BMC Biotechnol; 2007 Mar; 7():14. PubMed ID: 17346344
[TBL] [Abstract][Full Text] [Related]
14. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair.
Strop P; Ho WH; Boustany LM; Abdiche YN; Lindquist KC; Farias SE; Rickert M; Appah CT; Pascua E; Radcliffe T; Sutton J; Chaparro-Riggers J; Chen W; Casas MG; Chin SM; Wong OK; Liu SH; Vergara G; Shelton D; Rajpal A; Pons J
J Mol Biol; 2012 Jul; 420(3):204-19. PubMed ID: 22543237
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Antibody Selections by Combining Phage and Yeast Display.
Ferrara F; Soluri MF; Sblattero D
Methods Mol Biol; 2019; 1904():339-352. PubMed ID: 30539479
[TBL] [Abstract][Full Text] [Related]
16. Isolating and engineering human antibodies using yeast surface display.
Chao G; Lau WL; Hackel BJ; Sazinsky SL; Lippow SM; Wittrup KD
Nat Protoc; 2006; 1(2):755-68. PubMed ID: 17406305
[TBL] [Abstract][Full Text] [Related]
17. Isolation of human monoclonal antibodies by mammalian cell display.
Beerli RR; Bauer M; Buser RB; Gwerder M; Muntwiler S; Maurer P; Saudan P; Bachmann MF
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14336-41. PubMed ID: 18812621
[TBL] [Abstract][Full Text] [Related]
18. Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients.
Iizuka A; Komiyama M; Tai S; Oshita C; Kurusu A; Kume A; Ozawa K; Nakamura Y; Ashizawa T; Yamamoto A; Yamazaki N; Yoshikawa S; Kiyohara Y; Yamaguchi K; Akiyama Y
Immunol Lett; 2011 Mar; 135(1-2):64-73. PubMed ID: 20932861
[TBL] [Abstract][Full Text] [Related]
19. Mammalian cell display for the discovery and optimization of antibody therapeutics.
Bowers PM; Horlick RA; Kehry MR; Neben TY; Tomlinson GL; Altobell L; Zhang X; Macomber JL; Krapf IP; Wu BF; McConnell AD; Chau B; Berkebile AD; Hare E; Verdino P; King DJ
Methods; 2014 Jan; 65(1):44-56. PubMed ID: 23792919
[TBL] [Abstract][Full Text] [Related]
20. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
